Mitchell Ms
-
- Immunotherapy and Immune Responses 8
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies 2
-
- Cancer Immunotherapy and Biomarkers 3
- Cancer Diagnosis and Treatment 2
-
- vaccines and immunoinformatics approaches 3
- RNA Interference and Gene Delivery 2
-
- Lung Cancer Treatments and Mutations 3
-
- Monoclonal and Polyclonal Antibodies Research 2
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (20 papers)
- Partner nations
- United StatesAustralia
In The Last Decade
Mitchell Ms
19 papers receiving 377 citations
Peers
Comparison fields: 5 of 81
- Immunology 151
- Otorhinolaryngology 29
- Oncology 177
- Hematology 46
- Dermatology 23
Countries citing papers authored by Mitchell Ms
This map shows the geographic impact of Mitchell Ms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Ms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Ms more than expected).
Fields of papers citing papers by Mitchell Ms
This network shows the impact of papers produced by Mitchell Ms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Ms. The network helps show where Mitchell Ms may publish in the future.
Co-authorship network
The 18 scholars most cited alongside Mitchell Ms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | New trends in the development of cancer vaccines. | 1999 | 9 |
| 2 | The effect of bioburden on in-depth disinfection of denture base acrylic resin. | 1998 | 6 |
| 3 | Perspective on allogeneic melanoma lysates in active specific immunotherapy. | 1998 | 82 |
| 4 | Regarding breast cancer as an immunologically responsive tumor. | 1995 | 1 |
| 5 | The management of depression. Part 2. The place of the new antidepressants. | 1994 | 9 |
| 6 | Active specific immunotherapy of melanoma: clinical results and correlates. | 1993 | 2 |
| 7 | Chemotherapy in combination with biomodulation: a 5-year experience with cyclophosphamide and interleukin-2. | 1992 | 29 |
| 8 | Active specific immunotherapy in the treatment of human cancers. | 1989 | 2 |
| 9 | Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma. | 1986 | 19 |
| 10 | Staphylococcal protein A immunoadsorptive column induces mitogenicity in perfused plasma. | 1984 | 7 |
| 11 | Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities. | 1982 | 22 |
| 12 | Metabolism of methotrexate in man after high and conventional doses. | 1980 | 15 |
| 13 | Immunological methods in diagnosis and monitoring of head and neck cancer. | 1978 | 0 |
| 14 | Pulmonary granulomas in a patient on MER therapy. | 1978 | 3 |
| 15 | Transient warm autoimmune hemolytic anemia and cryoglobulinemia associated with seminoma. | 1977 | 8 |
| 16 | Cell-mediated immunity and blocking factor in ovarian carcinoma. | 1976 | 21 |
| 17 | Studies on the immunogical effects of BCG and its components: theoritical and therapeutic implications. | 1976 | 5 |
| 18 | Improved therapeutic index of methotrexate with "leucovorin rescue". | 1973 | 123 |
| 19 | The Yale combination chemotherapy program for advanced Hodgkin's disease. A preliminary report. | 1970 | 2 |
| 20 | Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck. | 1968 | 48 |
About Mitchell Ms
Mitchell Ms is a scholar working on Otorhinolaryngology, Immunology and Oncology, having authored 21 papers that have together received 415 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (3 papers), vaccines and immunoinformatics approaches (3 papers), Lung Cancer Treatments and Mutations (3 papers), RNA Interference and Gene Delivery (2 papers), Cancer Diagnosis and Treatment (2 papers), Head and Neck Cancer Studies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Immunology (151 citations), Otorhinolaryngology (29 citations) and Oncology (177 citations). Mitchell Ms has collaborated with scholars based in United States and Australia. Frequent co-authors include Bertino, Papac Rj, Martin Levitt, Thomas Ed, Kaplan, Rose J. Papac, Philip B. Mitchell, Stephan Ariyan, Kirkwood Jm and Daniëls. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.